At GEA we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product life-cycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Our solution for continuous tableting lines is ConsiGma®, a 6 sigma-inspired manufacturing platform, incorporating different technologies to produce oral solid dosage forms in a continuous, cost-efficient way:
Weergegeven 4 van 6
The ConsiGma® CF20 test rig is a standalone module that allows you to characterize the feeding behavior of your products during the early stages of R&D.
An indispensable part of the ConsiGma 4.0 portfolio, the Conductor 4.0 control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line
A highly integrated solution for continuous linear blending and direct compression, the ConsiGma® DC-LB lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled blending and compression and improved quality.
Designed to achieve optimal blending results, the ConsiGma® DB modules facilitate the testing of dosing and blending operations and can be integrated with any continuous up- or downstream process.
Elke druppel en elke kilowattuur telt als het gaat om de ontwikkeling van centrifuges. GEA bouwt al meer dan 130 jaar centrifuges - iets waarvan je niet zou denken dat het elke dag ter discussie staat. Jürgen Mackel, Vice President...
Door te investeren in hernieuwbare energie verlaagt GEA zijn CO2-uitstoot over de hele wereld.
Als het aankomt op het verbeteren van de gezondheid van de planeet, voert GEA de toon aan. Als een van onze strategische, op duurzaamheid gerichte doelstellingen effenen we de weg om onze klanten in tal van industrieën te helpen...